WO2001096321A1 - Process for the preparation of thiazolidinedione derivatives - Google Patents

Process for the preparation of thiazolidinedione derivatives Download PDF

Info

Publication number
WO2001096321A1
WO2001096321A1 PCT/JP2001/004989 JP0104989W WO0196321A1 WO 2001096321 A1 WO2001096321 A1 WO 2001096321A1 JP 0104989 W JP0104989 W JP 0104989W WO 0196321 A1 WO0196321 A1 WO 0196321A1
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
reaction
mol
general formula
derivative
Prior art date
Application number
PCT/JP2001/004989
Other languages
French (fr)
Japanese (ja)
Inventor
Michiro Ohnota
Kazuo Orita
Yasuhiro Aizawa
Noriyuki Yoshida
Takashi Sakamaki
Original Assignee
Kyorin Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co., Ltd. filed Critical Kyorin Pharmaceutical Co., Ltd.
Priority to AU2001274502A priority Critical patent/AU2001274502A1/en
Publication of WO2001096321A1 publication Critical patent/WO2001096321A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members

Definitions

  • the present invention is useful as a hypoglycemic agent and an insulin sensitivity enhancer.
  • the present invention relates to a method for producing a benzylthiazolidinedione derivative represented by the general formula (2), which is a synthetic intermediate for producing an N-benzyldioxothiazolidinyl benzamide derivative.
  • the N-benzyldioxothiazolidinyl benzamide derivative is known as a compound having an excellent hypoglycemic effect and hypolipidemic effect (Japanese Patent Application Laid-Open No. Hei 9-48771).
  • Japanese Patent Application Laid-Open No. Hei 9-48771 Japanese Patent Application Laid-Open No. Hei 9-48771.
  • a high-pressure catalytic reduction method using palladium carbon as a catalyst has been known (Japanese Patent Application Laid-Open No. H08-106468). It was done.
  • the present inventors have conducted intensive studies on the production of raw materials for establishing an industrial production method of an N-benzyldioxothiazolidinyl benzamide derivative.
  • R represents hydrogen or a lower alkyl group.
  • the present inventors have found that a benzylthiazolidinedione derivative represented by the formula (1) can be obtained with good yield, high purity and stability, and have completed the present invention.
  • the compound represented by the general formula (1) of the present invention can be synthesized by the method described in JP-A-9-48771.
  • the group defined as R is hydrogen or a lower alkyl group, which is a methyl group, an ethyl group, or an isopropyl group.
  • R of the compound of the general formula (1), which is a raw material may be either hydrogen or a lower alkyl group.
  • hydrolysis proceeds easily in the reaction system, and as a result, carboxylic acid is produced. Changes to acid groups.
  • reaction solvent in the production method of the present invention examples include aqueous solutions of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and the like, and these aqueous solutions and dimethylformamide, tetrahydrofuran.
  • a mixed solvent with an organic solvent such as drofuran, methanol, ethanol, and isopropyl alcohol can be used.
  • it is a 0.5 to 1 mol / L aqueous sodium hydroxide solution.
  • the temperature range of the reaction is 0-50 ° C. Preferably, it is 20 to 40 ° C.
  • Co complex catalyst used in the present invention examples include, for example, black (pyridyl) covaloxime (III) synthesized by the method described in In 0 rg. Synth. 11, 61 (19668). Can be used, but there is the trouble of separately preparing the catalyst.
  • the feature of the present invention is the same reaction In the system, C 0 ( ⁇ ) and dimethylglyoxime are used to form a C 0 complex catalyst within a specific pH range, and a reduction reaction is performed.
  • the donor of the Co (II) ion is preferably cobalt chloride, and the preferred ligand is dimethylglyoxime. This ligand is preferably used in an amount of about 4 mol% with respect to cobalt.
  • the preparation amount of the C0 catalyst used in the reaction is 0.1 to 1.5 fflol% based on the compound represented by the general formula (1). Preferably, it is 0.5 to 1.0 mol%.
  • borohydride compounds such as sodium borohydride, lithium borohydride, and borohydride can be used.
  • sodium borohydride can be used at low cost.
  • the pH of the reaction system can be set arbitrarily, but the reaction speed or the like changes significantly depending on the pH, which greatly affects the result of the reaction.
  • the compound of the present invention for example, although the reduction reaction proceeds even at pH 9.5 or more, the raw material compound (1) does not completely disappear. In order to completely eliminate the raw materials, it is necessary to add a catalyst and a reducing agent again, and it takes a long time to complete the reaction.
  • the thiazolidine-2,4-dione ring is relatively unstable under basic conditions, and therefore, it is disadvantageous to leave it under strong basic conditions for a long time.
  • the compound of the general formula (1) is prepared in a reaction system at a pH of 8.0 to 9.5 with a C 0 complex catalyst, and the reduction reaction is carried out.
  • This is a major feature of the invention.
  • the reduction reaction is completed in a short time, and the compound of the general formula (2) is produced with good reproducibility and good quality, which is an excellent method for industrial production. .
  • the precipitated crystals were collected by filtration and washed with water, ethanol, and getyl ether (50 mL each). The crystals were dried under reduced pressure at room temperature to obtain kuroguchi (pyridine) kovaloxim (III) 8.6.

Abstract

An industrially advantageous process for the preparation of a benzylthiazolidinedione derivative useful as an intermediate in the preparation of N-benzyldioxothiazolidinyl-benzamide derivatives serving as antihyperglycemics. Specifically, a process for the preparation of a thiazolidinedione derivative of formula (1), characterized by forming a Co complex catalyst in a specified pH range in a reaction system where the subsequent reduction is to be carried out, and reducing a compound of the general formula (2) with a reducing agent in the resulting reaction system (2) (wherein R is hydrogen or lower alkyl).

Description

曰月 糸田 チアゾリジンジオン誘導体の製造方法 技術分野  Satsuki Itoda Method for producing thiazolidinedione derivative Technical field
本発明は、 血糖降下剤及びィンス リ ン感受性増強剤として有用な The present invention is useful as a hypoglycemic agent and an insulin sensitivity enhancer.
N—ベンジルジォキソチアゾリジニルベンズアミ ド誘導体を製造す るにあたり、 その合成中間体である一般式 ( 2 ) で表されるベンジ ルチアゾリ ジンジオン誘導体の製造方法に関する。 The present invention relates to a method for producing a benzylthiazolidinedione derivative represented by the general formula (2), which is a synthetic intermediate for producing an N-benzyldioxothiazolidinyl benzamide derivative.
Figure imgf000003_0001
背景技術
Figure imgf000003_0001
Background art
N—ベンジルジォキソチアゾリジニルベンズアミ ド誘 体は優れ た血糖低下作用及び脂質低下作用を有する化合物として公知である (特開平 9 一 4 8 7 7 1 ) 。 これら一連の化合物を製造するには一 般式 ( 1 ) で表されるベンジリデンチァゾリジンジオン誘導体を還 元し、 ベンジルチアゾリジンジオン誘導体とする必要があった。 従 来、 この形のチアゾリジンジオン誘導体の還元方法としては、 パラ ジゥム炭素を触媒とした高圧接触還元法が知られており (特開平 8 一 1 0 4 6 8 8 ) 、 同様の方法で還元が行われていた。  The N-benzyldioxothiazolidinyl benzamide derivative is known as a compound having an excellent hypoglycemic effect and hypolipidemic effect (Japanese Patent Application Laid-Open No. Hei 9-48771). In order to produce these series of compounds, it was necessary to reduce the benzylidenethiazolidinedione derivative represented by the general formula (1) to a benzylthiazolidinedione derivative. Conventionally, as a method for reducing this form of thiazolidinedione derivative, a high-pressure catalytic reduction method using palladium carbon as a catalyst has been known (Japanese Patent Application Laid-Open No. H08-106468). It was done.
しかしながら、 この方法は多量の触媒と高圧接触還元装置が必要 なため、 安全な大量合成に適した方法とは言えなかった。  However, this method required a large amount of catalyst and a high-pressure catalytic reduction unit, and was not suitable for safe mass synthesis.
一方、 このようなチアゾリジンジオン誘導体を還元する別の方法 と して、 水素化ホウ素ナ ト リウムとコバルト錯体を用いて還元する 例 (特表平 7 - 5 0 2 5 3 0 ) が知られていた。 しかし本発明に関 わるべンジリデンチァゾリジンジオン誘導体の還元に利用できるか どうかは未知であった。 さらに、 この特表平 7— 5 0 2 5 3 0に記 載の方法をそのまま本発明に関わるベンジリデンチァゾリジンジォ ン誘導体に応用した場合、 収率、 純度にばらつきが大きく、 反応の 再現性に乏しいため、 工業的に有利な方法とは言えず、 工夫、 改良 する必要があった。 · 発明の開示 On the other hand, another method for reducing such thiazolidinedione derivatives For example, an example of reduction using sodium borohydride and a cobalt complex (Japanese Patent Application Laid-Open No. 7-520530) has been known. However, it was unknown whether it could be used for the reduction of the benzylidenethiazolidinedione derivative according to the present invention. Furthermore, when the method described in JP-T-Hei 7-5202530 is directly applied to the benzylidene thiazolidinedione derivative according to the present invention, the yield and purity vary greatly and the reproducibility of the reaction increases. Therefore, it was not an industrially advantageous method, and it was necessary to devise and improve it. · Disclosure of the invention
本発明者らは、 N—ベンジルジォキソチアゾリジニルベンズアミ ド誘導体の工業的製造方法を確立するため、 その原料の製造につい て鋭意研究を重ねた結果、  The present inventors have conducted intensive studies on the production of raw materials for establishing an industrial production method of an N-benzyldioxothiazolidinyl benzamide derivative.
一般式 ( 1 ) General formula (1)
Figure imgf000004_0001
Figure imgf000004_0001
[式中、 Rは水素又は低級アルキル基を表す。 ] [In the formula, R represents hydrogen or a lower alkyl group. ]
で表される化合物に、 同一の反応系内において、 特定の p H範囲内 で、 C o錯体触媒を形成させ、 次いで還元剤を作用させることによ り、 室温で迅速に還元反応が進行し、 ' 一般式 ( 2 )
Figure imgf000005_0001
By forming a Co complex catalyst in the same reaction system within a specific pH range and then using a reducing agent in the same reaction system, the reduction reaction proceeds rapidly at room temperature. , 'General formula (2)
Figure imgf000005_0001
で表されるベンジルチアゾリジンジオン誘導体が収率、 純度良く ま た安定して得られることを見いだし、本発明を完成したものである。 The present inventors have found that a benzylthiazolidinedione derivative represented by the formula (1) can be obtained with good yield, high purity and stability, and have completed the present invention.
本発明の一般式 ( 1 ) で表される化合物は、 特開平 9— 48 7 7 1に記載の方法により、 合成することができる。 一般式 ( 1 ) にお いて、 Rと して定義される基は水素又は低級アルキル基であり、 そ れはメチル基、 ェチル基あるいはイソプロピル基である。 原料であ る一般式 ( 1 ) の化合物の Rは水素か低級アルキル基のいづれの場 合でも良いが、 低級アルキルキの場合、 反応系中で加水分解が容易 に進行し、 結果と してカルボン酸基に変化する。  The compound represented by the general formula (1) of the present invention can be synthesized by the method described in JP-A-9-48771. In the general formula (1), the group defined as R is hydrogen or a lower alkyl group, which is a methyl group, an ethyl group, or an isopropyl group. R of the compound of the general formula (1), which is a raw material, may be either hydrogen or a lower alkyl group. In the case of a lower alkyl group, hydrolysis proceeds easily in the reaction system, and as a result, carboxylic acid is produced. Changes to acid groups.
本発明の製法における反応溶媒としては、 水酸化ナ ト リ ウム、 水 酸化カ リ ウム、 炭酸ナ ト リ ウム、 炭酸カ リ ウムなどの水溶液及びこ れらの水溶液とジメチルホルムアミ ド、 テ トラヒ ドロフラン、 メタ ノール、 エタノール、 イソプロピルアルコールなどの有機溶媒との 混合溶媒を用いることができる。 好ましくは、 0. 5〜 lmol/L の 水酸化ナ ト リゥム水溶液である。  Examples of the reaction solvent in the production method of the present invention include aqueous solutions of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate and the like, and these aqueous solutions and dimethylformamide, tetrahydrofuran. A mixed solvent with an organic solvent such as drofuran, methanol, ethanol, and isopropyl alcohol can be used. Preferably, it is a 0.5 to 1 mol / L aqueous sodium hydroxide solution.
反応の温度範囲は 0〜 5 0°Cである。 好ましくは、 20〜40°C である。  The temperature range of the reaction is 0-50 ° C. Preferably, it is 20 to 40 ° C.
本発明に用いる C o錯体触媒としては、 例えば I n 0 r g . S y n t h . 1 1、 6 1 ( 1 9 6 8 ) 記載の方法によ り合成されるクロ 口 (ピリジル) コバロキシム (III) 等を用いることができるが、 触 媒を別途に調製する煩わしさがある。 本発明の特徴は、 同一の反応 系内で、 特定の p H範囲内において C o (Π)とジメチルグリオキシ ムによ り C 0錯体触媒を形成さ'せ、 還元反応を行うものである。 Examples of the Co complex catalyst used in the present invention include, for example, black (pyridyl) covaloxime (III) synthesized by the method described in In 0 rg. Synth. 11, 61 (19668). Can be used, but there is the trouble of separately preparing the catalyst. The feature of the present invention is the same reaction In the system, C 0 (Π) and dimethylglyoxime are used to form a C 0 complex catalyst within a specific pH range, and a reduction reaction is performed.
C o (II) イオンの供与体は、 塩化コバルトが好ましく、 好ましい 配位子はジメチルグリオキシムである。 この配位子はコバル卜に対 し 4倍モル%程度の量が好適である。 The donor of the Co (II) ion is preferably cobalt chloride, and the preferred ligand is dimethylglyoxime. This ligand is preferably used in an amount of about 4 mol% with respect to cobalt.
反応に用いる C 0触媒調製量は、 一般式 ( 1 ) で表される化合 物に対して 0. 1〜 1. 5fflol%である。 好ましくは、 0. 5〜 1. 0mol%である。  The preparation amount of the C0 catalyst used in the reaction is 0.1 to 1.5 fflol% based on the compound represented by the general formula (1). Preferably, it is 0.5 to 1.0 mol%.
還元剤としては、 水素化ホウ素ナ ト リ ゥム、 水素化ホウ素リチウム、 水素化ホウ素力 リ ゥムなどの水素化ホウ素化合物を用いることがで きる。 好ましくは、 水素化ホウ素ナ ト リ ウムが安価に利用できる。 本反応を実施する際、 反応系の p Hは任意に設定し得るが、 p H により反応速度等が著しく変化し、 反応の成果に大きく影響を与え る。 本発明化合物において、 例えば、 還元反応は p H 9. 5以上で も進行はするものの、 原料化合物(1)が完全に消失しない。原料を完 全に消失させるためには、 さらに触媒や還元剤を再度添加する必要 があ り、 反応完結には長時間を必要とする。 一般に、 チアゾリジン - 2 , 4ージオン環は塩基性条件下では比較的不安定であるため、 長時間強い塩基性条件下に置く ことは、 製造上不利である。 As the reducing agent, borohydride compounds such as sodium borohydride, lithium borohydride, and borohydride can be used. Preferably, sodium borohydride can be used at low cost. In carrying out this reaction, the pH of the reaction system can be set arbitrarily, but the reaction speed or the like changes significantly depending on the pH, which greatly affects the result of the reaction. In the compound of the present invention, for example, although the reduction reaction proceeds even at pH 9.5 or more, the raw material compound (1) does not completely disappear. In order to completely eliminate the raw materials, it is necessary to add a catalyst and a reducing agent again, and it takes a long time to complete the reaction. In general, the thiazolidine-2,4-dione ring is relatively unstable under basic conditions, and therefore, it is disadvantageous to leave it under strong basic conditions for a long time.
上述の課題を解決するため、 一般式 ( 1 ) の化合物を還元するに あたり、 反応液中で C 0錯体触媒を形成させ、 次いで還元剤を添加 し、 還元を行わせる際の p Hについて検討したところ、 p H 8. 0 〜 9. 5において反応操作を行う と、 高純度のベンジルチアゾリジ ンジオン誘導体 ( 2 ) が高収率で、 再現性良く得られる事が判明し たものである。  In order to solve the above-mentioned problems, when reducing the compound of the general formula (1), the pH at the time of forming a C 0 complex catalyst in the reaction solution, then adding a reducing agent and performing reduction is examined. As a result, it was found that high-purity benzylthiazolidinedione derivative (2) can be obtained with high yield and high reproducibility when the reaction is performed at pH 8.0 to 9.5. .
即ち、 一般式 ( 1 ) の化合物を p H 8. 0〜 9. 5範囲において、 C 0錯体触媒を反応系中で調製し、 還元反応を行わせることが、 本 発明の大きな特徴である。 これによつて、 短時間で還元反応が終結 し、 しかも再現性良く、 良好な品質の一般式 ( 2 ) の化合物が製造 されるるので、 工業的製造する方法と して優れてたものである。 発明を実施するための最良の形態 That is, the compound of the general formula (1) is prepared in a reaction system at a pH of 8.0 to 9.5 with a C 0 complex catalyst, and the reduction reaction is carried out. This is a major feature of the invention. As a result, the reduction reaction is completed in a short time, and the compound of the general formula (2) is produced with good reproducibility and good quality, which is an excellent method for industrial production. . BEST MODE FOR CARRYING OUT THE INVENTION
以下に実施例を示して, 本発明を更に詳細に説明するが, 本発明 はこれら実施例によって何等の制限を受けるものではない。  Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited by these Examples.
(参考例 1) (Reference example 1)
5— [ ( 2 , 4—ジォキソチアゾリジン一 5—イ リデン) メチル]一 2—メ トキシ安息香酸メチルエステルの合成  Synthesis of 5-[(2,4-dioxothiazolidine-1-5-ylidene) methyl] -1-2-methoxybenzoic acid methyl ester
1 ) 5—ホルミルサリチル酸 3 3 2. 3 g ( 2. O Omol) を アセ トン 1. 6 6L に懸濁した後、 1 0 °C以下に冷却した。 炭酸力 リ ウム 5 5 2. 8 g ( 4. 0 Omol) を加え、 1 0°C以下でジメチ ル硫酸(純度 9 5 %) 5 3 1. 1 ( 4. 0 Omol) を滴下した。 滴 下後、 2時間撹拌して、 さらに 1時間還流した。 反応液を室温まで 冷却し、 冷水 3. 3 2 Lに注ぎ、 さらに 水 3. 3 2 Lを滴下し、 室温で 1時間撹拌した。 結晶をろ取して水 3. 3 2Lで洗浄後、 4 0°Cで一夜送風乾燥して 3—ホルミル- 6—メ トキシ安息香酸メチ ルエステルを 3 3 5. 4 g ( 8 6. 4 %) 得た。 1) 52.3-Formylsalicylic acid was suspended in 1.66 L of acetone, and then cooled to 10 ° C or lower. 52.8 g (4.0 Omol) of lithium carbonate was added, and dimethyl sulfate (purity: 95%) 53.1 (4.0 Omol) was added dropwise at 10 ° C or lower. After the addition, the mixture was stirred for 2 hours and refluxed for another 1 hour. The reaction solution was cooled to room temperature, poured into 3.32 L of cold water, and 3.32 L of water was added dropwise, followed by stirring at room temperature for 1 hour. The crystals were collected by filtration, washed with 3.32 L of water, and dried by blowing air at 40 ° C overnight to give 33.5.4 g (86.4%) of methyl 3-formyl-6-methoxybenzoate. ) Obtained.
m.p. 84〜 8 6 °C。  m.p. 84-86 ° C.
2 ) 3—ホルミル一 6—メ トキシ安息香酸メチルエステル 3 1 0. 7 g ( 1 . 6 Oraol) をエタノール 1 . 5 5Lに懸濁した後、 2 , 4—チアゾリジンジオン 2 2 4. 9 g ( 1. 9 2 mol) 及び ピ ペリジン 1 3 6. 3 g ( 1 . 6 Omol) を加え、 還流下 6時間反応 した。 室温まで冷却した後、 反応液を冷水 3. 1 1Lに注いで冷却 しながら濃塩酸を滴下し、 pH2〜 3 とした。 3 0分間撹拌後、 結晶 をろ取してろ液が中性になるまで水洗した。 得られた湿潤粗結晶を メタノール 4. 6 9L に還流下 30分間懸濁した。 室温まで冷却し た後、 結晶をろ取してメタノール 1 . 4 1 Lで洗浄した。 6 0°Cで 送風乾燥し、 5— [ ( 2, 4—ジォキソチアゾリ ジン一 5—イ リ デン) メチル] 一 2—メ トキシ安息香酸メチルエステル 3 7 7. 7 g ( 8 0. 5 %) を得た。 2) 3-Formyl-l-6-methoxybenzoic acid methyl ester 30.7 g (1.6 Oraol) was suspended in 1.55 L of ethanol, and then 2,4-thiazolidinedione was 24.9 g. (1.92 mol) and 13.6.3 g (1.6 Omol) of piperidine were added, and the mixture was reacted under reflux for 6 hours. did. After cooling to room temperature, the reaction solution was poured into 3.11 L of cold water, and concentrated hydrochloric acid was added dropwise while cooling to adjust the pH to 2-3. After stirring for 30 minutes, the crystals were collected by filtration and washed with water until the filtrate became neutral. The obtained wet crude crystals were suspended in 4.69 L of methanol for 30 minutes under reflux. After cooling to room temperature, the crystals were collected by filtration and washed with 1.41 L of methanol. Blow-dry at 60 ° C and dry with 5-[(2,4-dioxothiazolidin-1-5-ylidene) methyl] -12-methoxybenzoic acid methyl ester 37.7.7 g (80.5%) I got
m.p. 2 7 3〜 2 7 6 °C。  m.p. 273-276 ° C.
(参考例 2 ) (Reference example 2)
2—メ トキシー 5— [ ( 2 , 4—ジォキソチアゾリジン一 5—ィ リデ ン) メチル]安息香酸の合成  Synthesis of 2-Methoxy-5-[(2,4-Dioxothiazolidine-1-lylidene) methyl] benzoic acid
5— [ ( 2 , 4—ジォキソチアゾリジン一 5—ィ リデン) メチル] 一 2—メ トキシ安息香酸メチルエステル 3 7 0. 0 g ( 1. 2 6 mol) を l mol/Lの水酸化ナ ト リ ゥム水溶液 3. 7 8 L ( 3. 7 8 mol) に 加え、 室温で 3時間撹拌した。 その後、 活性炭 3. 7 gを加えてさ らに 1時間撹拌した。 活性炭をセライ トを用いてろ別し、 水 3. 7 8Lで洗浄した。 ろ液に水 3. 7 8Lを加えた後、 6mol/Lの塩酸 を加えて PH2〜 3に調整した。 1時間撹拌後、 結晶をろ取してろ液 が中性になるまで水洗した。 湿潤粗結晶をァセ トン 3. 5L で還流 下 3 0分間懸濁した。 室温まで冷却した後、 結晶をろ取してァセ ト ン 1. ◦ 6L で洗浄した。 5 0°Cで送風乾燥し、 5— [ ( 2 , 4— ジォキソチアゾリジン一 5—ィ リデン)メチル]一 2—メ トキシ安息 香酸 2 8 5. 3 g ( 8 1. 0 %) を得た。 5-[(2,4-Dioxothiazolidine-1-5-ylidene) methyl] methyl 2--1-methoxybenzoate 370.0 g (1.26 mol) of l-mol / L hydroxylation The solution was added to 3.78 L (3.78 mol) of a sodium aqueous solution, and stirred at room temperature for 3 hours. Thereafter, 3.7 g of activated carbon was added, and the mixture was further stirred for 1 hour. The activated carbon was filtered off using celite and washed with 3.78 L of water. After adding 3.78 L of water to the filtrate, 6 mol / L hydrochloric acid was added to adjust the pH to 2-3. After stirring for 1 hour, the crystals were collected by filtration and washed with water until the filtrate became neutral. The wet crude crystals were suspended in 3.5 L of acetone for 30 minutes under reflux. After cooling to room temperature, the crystals were collected by filtration and washed with 1.6 L of acetone. Dry with air at 50 ° C and dry 5-([2,4-dioxothiazolidine-1-5-ylidene) methyl] -12-methoxybenzoic acid 28.5.3 g (81.0%) I got
m.p. 2 6 8〜 2 7 0。C。 (参考例 3 ) mp 268-270. C. (Reference example 3)
クロ口 (ピリジン) コバロキシム (III) の調製 Preparation of black mouth (pyridine) covaloxime (III)
40 0 mLの 9 5 %ェ夕ノ一ルに、塩化コバルト(Π) 6水和物 1 0. 0 g、 ジメチルダリオキシム 1 1. 0 gを加えて加温溶解し、 ピリジン 6. 8 8 gを加えて撹拌した。 2 0°Cまで冷却し、 反応液 中に 3 0分間空気を吹き込み同温度で 1時間放置した。 To 400 mL of 95% ethanol, 10.0 g of cobalt chloride (II) hexahydrate and 11.0 g of dimethyldalioxime were added and dissolved by heating. g was added and stirred. After cooling to 20 ° C, air was blown into the reaction solution for 30 minutes and left at the same temperature for 1 hour.
析出晶をろ取し、 水、 エタノール、 ジェチルエーテル(各 5 0 mL) の順に洗浄した。 室温下減圧乾燥してクロ口 (ピリジン) コバロキ シム (III) 8. 6 を得た。  The precipitated crystals were collected by filtration and washed with water, ethanol, and getyl ether (50 mL each). The crystals were dried under reduced pressure at room temperature to obtain kuroguchi (pyridine) kovaloxim (III) 8.6.
(参考例 4 ) (Reference example 4)
5— [ ( 2 , 4—ジォキソチアゾリジン一 5—イ リデン) メチル] 一 2—メ トキシ安息香酸 5 0. 0 を 2 5°〇の 0. 5mol/L 水酸化 ナ ト リ ゥム水溶液 72 0 mL に投入して溶解した。 水素化ホウ素ナ ト リ ウム 6. 8 gを投入した後、 クロ口 (ピリジン) コバロキシ ム (III) 0. 3 6 gを加えて 2 5 °Cで 6. 5時間反応した。 反応液 を氷水冷却し、 5 0 %イ ソプロピルアルコール、 水 7 2 0 mL を加 えた後、 6mol/Lの塩酸を滴下して pH 2とした。氷水泠却下 1時間 撹拌して析出晶をろ取し、 1 0 %イソプロピルアルコール水溶液 5 00 mLで洗浄した。  5-[(2,4-Dioxothiazolidine-1-5-ylidene) methyl] 1-2-Methoxybenzoic acid 50.0 0.5 mol / L sodium hydroxide aqueous solution at 25 ° C It was poured into 720 mL to dissolve. After charging 6.8 g of sodium borohydride, 0.36 g of chlorinated (pyridine) covaloxime (III) was added, and the mixture was reacted at 25 ° C for 6.5 hours. The reaction solution was cooled with ice water, 50% isopropyl alcohol and water (720 mL) were added, and 6 mol / L hydrochloric acid was added dropwise to adjust the pH to 2. The mixture was stirred for 1 hour while being cooled with ice water, and the precipitated crystals were collected by filtration and washed with 500 mL of a 10% aqueous isopropyl alcohol solution.
5 0°Cで送風乾燥して 5— [ ( 2, 4ージォキソチアゾリジン一 5 一ィル) メチル ]— 2—メ トキシ安息香酸 4 3. 5 g ( 8 6. 4 を得た。  It was dried by blowing air at 50 ° C to obtain 43.5 g (86.4) of 5-[(2,4-dioxothiazolidine-l-yl) methyl] -2-methoxybenzoic acid.
m.p. 1 8 7〜 1 8 9 °C。 (参考例 5 ) mp 187-189 ° C. (Reference example 5)
0. 5 mol/Lの水酸化ナ ト リ ゥム水溶液 4. 0 0 Lに 5 — [ ( 2 , 4ージォキソチアゾリジン _ 5 —ィ リデン)メチル]一 2—メ トキシ 安息香酸 2 7 9 . 3 g ( 1 . 0 Omol) を加えて溶解し、 1 0 °C以下 まで冷却した。 これに塩化コノ ルト 0. 6 5 ( 5 . 0 Ommol) 、 ジ メチルダリオキシム 2 . 3 2 g ( 2 0 . 0 mmol) 、 水素化ホウ素 ナ ト リ ウム 4 1 . 6 g ( 1 . l Omol) 及び D MF 4 0 0 mLを加え た。 室温で攪拌を続けたが、 未反応原料がみとめられたので、 3時 間後に、 水素化ホウ素ナ ト リ ウム 4 1 . 6 g ( 1 . 1 Omol) 、 さ ら に 1 Ί時間後に水素化ホウ素ナ ト リ ウム 3. 7 8 g ( 0 . 1 Omol) を追加した。 冷却下反応液に冷 5 0 %イソプロピルアルコール水溶 液 4. 0 0L を加えた後、 2 0 °C以下で 6 mol/Lの塩酸を滴下し、 p H 2〜 3 とした。  0.5 mol / L aqueous sodium hydroxide solution 4.0 — 5 — [(2,4 dioxothiazolidine_5—ylidene) methyl] 1-2-methoxybenzoic acid in 0.0L 2 7 9.3 g (1.0 Omol) was added and dissolved, and the mixture was cooled to 10 ° C or lower. This was followed by 0.65 (5.0 Ommol) of sodium chloride chloride, 2.32 g (20.0 mmol) of dimethyldalioxime, 41.6 g (1.1 Omol) of sodium borohydride. ) And 400 mL of DMF. Stirring was continued at room temperature, but unreacted raw materials were found.Three hours later, sodium borohydride 41.6 g (1.1 Omol) was added, and after another one hour, hydrogenation was performed. 3.78 g (0.1 Omol) of sodium boron was added. After adding 4.00 L of a cold 50% isopropyl alcohol aqueous solution to the reaction solution under cooling, 6 mol / L hydrochloric acid was added dropwise at 20 ° C. or lower to adjust the pH to 2-3.
冷却下 1時間撹拌し、 結晶をろ取後 1 0 %ィソプロピルアルコー ル水溶液 2 . 8 1 L で洗浄した。 5 0 °Cで送風乾燥し、 粗結晶を 2 2 9 . 2 g得た。 これに酢酸ェチル 2 . 2 9 L を加え、 還流下 3 0 分間懸濁して 2 0 °C以下まで冷却後、 結晶をろ取した。 結晶は酢酸 ェチル 1 . 1 5 L で洗浄後、 4 0 °Cで送風乾燥し、 5 — [ ( 2 , 4 ージォキソチアゾリジン一 5 —ィル)メチル]一 2 —メ トキシ安息香 酸 2 1 5 . 2 g ( 7 6 . 5 %) を得た。  After stirring for 1 hour under cooling, the crystals were collected by filtration and washed with 2.81 L of a 10% aqueous solution of isopropyl alcohol. It was blow-dried at 50 ° C. to obtain 229.2 g of crude crystals. To this, 2.29 L of ethyl acetate was added, suspended under reflux for 30 minutes, cooled to 20 ° C or lower, and the crystals were collected by filtration. The crystals were washed with 1.15 L of ethyl acetate, blown dry at 40 ° C, and dried with 5 — [(2,4 dioxothiazolidine-1-yl) methyl] 1-2—methoxybenzoic acid 2 15.2 g (76.5%) were obtained.
m.p. 1 8 7〜 1 8 9 °C 、 H P L C純度 9 8 . 0 0 %。  m.p. 187-189 ° C., HPLC purity 98.0%.
(実施例) (Example)
5 - [ ( 2 , 4—ジォキソチアゾリジン一 5 —イ リデン)メチル]— 2 —メ トキシ安息香酸メチルエステル 3 7. 6 g ( 0 . 1 2 8 mol) を 1 mol/L 水酸化ナ ト リ ゥム溶液 2 8 2 mL に加え、 3 0〜 3 5 °C で 2時間攪拌した。 2mol/L 塩酸を滴下して p H 9 . 1 3に調整し た。 これに塩化コバル ト 8 3 mg ( 0. 6 4 0 mmol) の水 5. 3 mL 溶液、 ジメチルグリオキシム 2 9 8 m g ( 2. 5 6 mmol ) のジ メチルホルムアミ ド ( D M F ) 3. 0 mL 溶液、 水素化ホウ素ナ ト リ ウム 2. 9 1 g ( 7 6. 9匪 ol ) を順次加え、 3 0〜 3 5 °Cで 2 時間攪拌した。 反応液にィソプロピルアルコール 2 8 2 mL を加え た後、 2 0〜 3 0 °Cで 6 mol/L 塩酸を滴下し、 p H 7. 8 1に調整 した。 活性炭 0. 3 8 gを投入し、 2 0〜3 0°Cで 3 0分間攪拌後。 不溶物をろ去した。 ろ液に 2 0〜 3 0 °Cで 6 mol/L塩酸を滴下し、 p H 2. 0 1に調整した。 冷却化結晶析出後、 0〜 5 °Cで 1時間 攪拌し、 結晶をろ取後、 1 0 %イソプロピルアルコール水溶液 3 7 6 mL で洗浄した。 湿潤粗結晶と して 4 6. 7 gを得た。 この湿潤 粗結晶 46. 1 gを水 1 5 7 mLに懸濁し、 2 mol/L水酸化ナ ト リ ゥ ム水溶液 8 3. 6 mL を加えて溶解した。 イソプロピルアルコール 1 2 0 mL及び D M F 2 1. 1 mL (水 : イソプロピルアルコール : DMF = 1 0 : 5 : 1になる量) を添加し、 6 mol/L塩酸を滴下し、 p H 2. 0 2に調整した。 2 0 °C以下で 1時間攪拌し、 結晶をろ 取後、 水 6 2. 7 mL で洗浄した。 6 0 °Cで 2 3時間送風乾燥し、 5— [ ( 2 , 4—ジォキソチアゾリジン一 5—ィル) メチル ]— 2— メ トキシ安息香酸を 30. 1 g ( 8 3. 6 %) 得た。 5-[(2,4-Dioxothiazolidine-1-5-ylidene) methyl] —2—Methoxybenzoic acid methyl ester 37.6 g (0.128 mol) was added to 1 mol / L sodium hydroxide. The solution was added to 28 mL of the stream solution, and the mixture was stirred at 30 to 35 ° C for 2 hours. 2 mol / L hydrochloric acid was added dropwise to adjust the pH to 9.13. Was. This was followed by a solution of 83 mg (0.640 mmol) of cobalt chloride in 5.3 mL of water, and 298 g (2.56 mmol) of dimethylglyoxime in 3.0 mL of dimethylformamide (DMF). mL solution and sodium borohydride (2.91 g, 76.9 marl ol) were sequentially added, and the mixture was stirred at 30 to 35 ° C for 2 hours. After adding 282 mL of isopropyl alcohol to the reaction solution, 6 mol / L hydrochloric acid was added dropwise at 20 to 30 ° C to adjust the pH to 7.81. After charging 0.38 g of activated carbon, the mixture was stirred at 20 to 30 ° C for 30 minutes. The insoluble matter was removed by filtration. 6 mol / L hydrochloric acid was added dropwise to the filtrate at 20 to 30 ° C., and the pH was adjusted to 2.01. After the cooled crystals were precipitated, the mixture was stirred at 0 to 5 ° C. for 1 hour, and the crystals were collected by filtration and washed with 1076% aqueous isopropyl alcohol solution (376 mL). 46.7 g was obtained as wet crude crystals. 46.1 g of the wet crude crystals were suspended in 157 mL of water, and dissolved by adding 83.6 mL of a 2 mol / L sodium hydroxide aqueous solution. Add 12.0 mL of isopropyl alcohol and 1.1 mL of DMF (water: isopropyl alcohol: DMF = 10: 5: 1), add 6 mol / L hydrochloric acid dropwise, and adjust the pH to 2.02. Was adjusted to The mixture was stirred at 20 ° C or lower for 1 hour, and the crystals were collected by filtration and washed with 62.7 mL of water. Blow dry at 60 ° C for 23 hours, and dry 30.1 g (83.6%) of 5 — [(2,4-dioxothiazolidine-1-yl) methyl] —2—methoxybenzoic acid. ) Obtained.
m.p. 1 8 8 °C, H P L C純度 9 9. 3 3 %。 産業上利用可能性  m.p. 18 88 ° C, HPLC purity 99.3 3%. Industrial applicability
抗糖尿病剤として開発されている N—ベンジルジォキソチアゾリ ジニルベンズアミ ド誘導体の工業的製造方法を確立するため、 その 原料であるカルボキシル基を有するベンジルチアゾリジンジオン誘 導体の工業的に優れた製造法を見出した。 即ち、 ベンジリデンチァ ゾリジンジオン誘導体を同一反応系中で、 p H 8. 0〜 9. 5範囲 において C o錯体触媒を形成させ、 還元剤により還元すれば、 短時 間で反応が終結し、 しかも再現性良く、 良好な品質のベンジルチア ゾリジンジオン誘導体を得ることができる。 本発明のチアゾリ ンジ オン誘導体の製造方法は、 操作法が簡便で再現性が高く、 高圧接触 還元装置等の特別な装置を使用する必要もなく、 安全で大量合成に 適した工業的製造方法を提供するものである。 In order to establish an industrial process for the production of N-benzyldioxothiazolidinyl benzamide derivatives, which are being developed as antidiabetic agents, an industrially superior process for producing a benzylthiazolidinedione derivative having a carboxyl group as a raw material Was found. That is, the benzylidene zolidinedione derivative was used in the same reaction system, and the pH range was 8.0 to 9.5. When a Co complex catalyst is formed in the above and the reduction is performed with a reducing agent, the reaction is completed in a short time, and a benzylthiazolidinedione derivative of good quality with good reproducibility can be obtained. The method for producing a thiazolindione derivative of the present invention is a simple and highly reproducible industrial method that does not require the use of a special device such as a high-pressure catalytic reduction device, and is suitable for mass synthesis. To provide.

Claims

言青求の範固 Speculation of Word
1. '般式 ( 1 )
Figure imgf000013_0001
1. General formula (1)
Figure imgf000013_0001
[式中、 Rは水素又は低級アルキル基を表す。 ] [In the formula, R represents hydrogen or a lower alkyl group. ]
で表される化合物を、 同一の反応系内において、 特定の p H範囲 内で、 C o錯体触媒を形成させ、 次いで還元剤を作用させて還元 するこ とを特徴とする一般式 ( 2 )
Figure imgf000013_0002
で表されるチアゾリジンジオン誘導体の製造方法
A compound represented by the general formula (2) characterized in that, in the same reaction system, a Co complex catalyst is formed within a specific pH range and then reduced by the action of a reducing agent.
Figure imgf000013_0002
For producing thiazolidinedione derivative represented by formula
2. 特定の p H範囲が 8. 0 9. 5のである請求項 1記載の製 造方法。 2. The method according to claim 1, wherein the specific pH range is 8.09.5.
3. 還元剤が水素化ホウ素化合物である請求項 1および 2記載の 製造方法。 3. The production method according to claim 1, wherein the reducing agent is a borohydride compound.
PCT/JP2001/004989 2000-06-14 2001-06-13 Process for the preparation of thiazolidinedione derivatives WO2001096321A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001274502A AU2001274502A1 (en) 2000-06-14 2001-06-13 Process for the preparation of thiazolidinedione derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000178135 2000-06-14
JP2000-178135 2000-06-14

Publications (1)

Publication Number Publication Date
WO2001096321A1 true WO2001096321A1 (en) 2001-12-20

Family

ID=18679610

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/004989 WO2001096321A1 (en) 2000-06-14 2001-06-13 Process for the preparation of thiazolidinedione derivatives

Country Status (2)

Country Link
AU (1) AU2001274502A1 (en)
WO (1) WO2001096321A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013095A1 (en) * 1991-12-20 1993-07-08 The Upjohn Company A reduction method for substituted 5-methylene-thiazolidinediones
JPH08277279A (en) * 1995-04-05 1996-10-22 Nitto Chem Ind Co Ltd Production of benzylthiazolidindione derivative
WO1996038428A1 (en) * 1995-06-02 1996-12-05 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013095A1 (en) * 1991-12-20 1993-07-08 The Upjohn Company A reduction method for substituted 5-methylene-thiazolidinediones
JPH08277279A (en) * 1995-04-05 1996-10-22 Nitto Chem Ind Co Ltd Production of benzylthiazolidindione derivative
WO1996038428A1 (en) * 1995-06-02 1996-12-05 Kyorin Pharmaceutical Co., Ltd. N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same

Also Published As

Publication number Publication date
AU2001274502A1 (en) 2001-12-24

Similar Documents

Publication Publication Date Title
EP1655282A1 (en) Hydroxynaphthoic acid hydrazide compounds and method for preparing the same
EP2370433A2 (en) A method for the preparation of tizanidine hydrochloride
EP1277745A1 (en) Novel stable crystal of thiazolidinedione derivative and process for producing the same
WO2001096321A1 (en) Process for the preparation of thiazolidinedione derivatives
CN111533710B (en) Method for preparing cefotiam intermediate 2-aminothiazole-4-acetic acid by one-pot method
US20220235010A1 (en) Synthesis method for 1-methyl-1h-indazole-6-carboxylic acid
CN111848535A (en) Process for synthesizing 1H-tetrazole acetic acid
SU576937A3 (en) Method of preparing mono-o-b-oxoethyl-7-rutine
CN111393382A (en) Preparation method of 1-tetrazole acetate
CN110452177A (en) A kind of synthetic method of the fluoro- 1H- indazole of the bromo- 4- of 5-
KR20060041266A (en) Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them
JPS6127984A (en) Phodanineacetic acid derivative
JP2799373B2 (en) Method for producing sodium azide
CA2487003C (en) Process for the preparation of ziprasidone (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one)
CN105968054B (en) Preparation of pimobendan key intermediate
JPS6122081A (en) Preparation of hydantoin compound
KR100499643B1 (en) Multi-substituted Aniline Compounds And Method For Preparing Them
JP2562872B2 (en) Method for synthesizing cyano-imidazole compound
CN103554053A (en) Method for preparing 2,4-thiazolidinedione
CN114249795A (en) Preparation method of enalapril maleate and intermediate thereof
JP4364663B2 (en) Process for producing ureido derivatives of hydroxynaphthalenecarboxylic acids
CN114890940A (en) Synthetic method of 6-methoxy-2-picolinic acid
SU729193A1 (en) Aminoalkylsalicylic acids as intermediates in azodyes synthesis
KR20240019353A (en) Intermediates of eldoxaban tosylate and methods for their preparation
JP2004520401A (en) Preparation of compounds derived from thiazolidinedione and oxazolidinedione

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase